Castle Biosciences (CSTL) Inventory Average (2019 - 2026)

Castle Biosciences has disclosed Inventory Average across 8 years of filings, most recently posting $10.4 million for Q1 2026.

• Inventory Average for Q1 2026 came in at $10.4 million, up 38.25% year-over-year; the trailing twelve-month figure through Mar 2026 was $10.4 million (up 38.25% YoY), and the FY2025 annual result was $9.2 million, up 14.38% from the prior year.
• Inventory Average came in at $10.4 million for Q1 2026 at Castle Biosciences, up from $9.5 million in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $10.4 million in Q1 2026 to a low of $2.2 million in Q1 2022.
• The 5-year median for Inventory Average is $7.3 million (2024), against an average of $6.4 million.
• Across the five-year window, Inventory Average jumped 94.46% in 2023 and declined 3.87% in 2025, its largest moves.
• Castle Biosciences' Inventory Average stood at $3.9 million in 2022, then jumped by 76.19% to $6.9 million in 2023, then rose by 7.26% to $7.4 million in 2024, then increased by 28.54% to $9.5 million in 2025, then rose by 9.58% to $10.4 million in 2026.
• The last three Inventory Average figures came in at $10.4 million (Q1 2026), $9.5 million (Q4 2025), and $8.5 million (Q3 2025), per Business Quant data.